Human Reproduction Update Advance Access originally published online on September 7, 2006
Human Reproduction Update 2007 13(1):15-25; doi:10.1093/humupd/dml043
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Current value of preimplantation genetic aneuploidy screening in IVF
1 Centre for Reproductive Medicine, 2 Centre for Medical Genetics, University Hospital, Dutch-speaking Brussels Free University (Vrije Universiteit Brussel), Brussels, Belgium and 3 Department of Reproductive Medicine, University Medical Center, Utrecht, The Netherlands
4 To whom correspondence should be addressed at: Centre for Reproductive Medicine, Dutch-speaking Brussels Free University (Vrije Universiteit Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium. E-mail: pdonoso{at}alemana.cl
| Abstract |
|---|
Preimplantation genetic aneuploidy screening (PGS) has been performed during the last decade as a way of enhancing embryo selection in patients with an increased incidence of embryonic numerical chromosome abnormalities (advanced maternal age, recurrent miscarriage and recurrent implantation failure). It has been proposed that the replacement of euploid embryos in these patients would result in a higher implantation and pregnancy rate and a reduced miscarriage rate. Additionally, the transfer of fewer embryos could reduce the chances for multiple pregnancies in all IVF patients. Although, to date, multiple studies have addressed this issue, contradictory results have been encountered. As a result, the effectiveness of aneuploidy screening remains to be established. Moreover, child outcome studies documenting the safety of this procedure are needed. The aim of this review is to summarize the available evidence concerning the use of PGS to determine the current value of the technique.
Key words: aneuploidy screening / embryo selection / preimplantation genetic diagnosis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Liebaers, S. Desmyttere, W. Verpoest, M. De Rycke, C. Staessen, K. Sermon, P. Devroey, P. Haentjens, and M. Bonduelle Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis Hum. Reprod., August 27, 2009; (2009) dep298v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Staessen, W. Verpoest, P. Donoso, P. Haentjens, J. Van der Elst, I. Liebaers, and P. Devroey Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer Hum. Reprod., December 1, 2008; 23(12): 2818 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C.J.M. Fauser Preimplantation genetic screening: the end of an affair? Hum. Reprod., December 1, 2008; 23(12): 2622 - 2625. [Full Text] [PDF] |
||||
![]() |
C. M. Ogilvie Preimplantation testing for chromosome aneuploidy Obstet Gynaecol (Lond), April 1, 2008; 10(2): 88 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M.H. Combelles What are the trade-offs between one-cell and two-cell biopsies of preimplantation embryos? Hum. Reprod., March 1, 2008; 23(3): 493 - 498. [Full Text] [PDF] |
||||
![]() |
P. Braude and F. Flinter Use and misuse of preimplantation genetic testing BMJ, October 13, 2007; 335(7623): 752 - 754. [Full Text] [PDF] |
||||
![]() |
A. Mantzouratou, A. Mania, E. Fragouli, L. Xanthopoulou, S. Tashkandi, K. Fordham, D.M. Ranieri, A. Doshi, S. Nuttall, J.C. Harper, et al. Variable aneuploidy mechanisms in embryos from couples with poor reproductive histories undergoing preimplantation genetic screening Hum. Reprod., July 1, 2007; 22(7): 1844 - 1853. [Abstract] [Full Text] [PDF] |
||||


